Journal of Clinical Psychopharmacology

Article	Citations
Trazodone and Mianserin for Delirium	45
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	36
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	34
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	30
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	24
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	21
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	20
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman	19
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	19
Author Index 2022	18
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	16
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	15
Possibly Misleading Pharmaceutical Advertising On TV	15
Dysphagia to Liquids Only Associated With Olanzapine	13
Postinjection Syndrome After Paliperidone?	13
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	13
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation	12
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy	12
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings	12
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	12
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine	12
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	12
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	12
Question	12
Thoughts on the Value of Case Series in the Literature	12

Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	11
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia	11
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior	11
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	11
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice	11
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus	11
Drug Interaction Between Clozapine and Rifampicin	10
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio	10
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders	10
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use	10
Drug-Associated Liver Injury Related to Antipsychotics	10
Neuroleptic Malignant Syndrome Associated With Lurasidone	10
Escitalopram-Associated Drug Rash	10
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin	10
Clozapine Once-Daily Versus Divided Dosing Regimen	10
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment	9
SALUTE TO OUR REVIEWERS	9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum	9
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy	9
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia	8
Restless Legs Syndrome Associated With Brexpiprazole	8
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders	8
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine	8
Untreated Mental Illness Has Created a National Tragedy	7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder	7
Journal of Clinical Psychopharmacology Updates	7
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns	7
Factors Associated With Poor Response to Clozapine in Schizophrenia	7
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104	7
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine	7
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression	7
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report	7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel	7
Question	7
Aripiprazole as First-Line Therapy for Late-Life Depression	7
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	7
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine	7
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine	7
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature	7
Incorporating Real-World Treatment Data Into Clozapine's Product Label	6
Limitations in Recent Study of Clozapine Use During Pregnancy	6
Use of Clozapine in Pregnancy	6
Clozapine-Associated Agranulocytosis	6
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review	6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	6
Alpha Lipoic Acid for Schizophrenia	6
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia	6
Pharmacokinetics of Ketamine Transfer Into Human Milk	6
Clozapine Use in Down Syndrome	6
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan	6

A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	6
A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials	6
Mania Associated With Cariprazine	6
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature	6
Mania-Like Reaction Secondary to Sodium Oxybate	6
Resolution of Catatonia With Cariprazine—A Case Report	6
Clozapine- and Lithium-Associated Myoclonus	6
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer	6
Plasma Clozapine in Treatment Refractory Schizophrenia	6
A Manic Episode With Psychotic Features Associated With Levetiracetam	6
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient	6
Valproic Acid–Associated Hyperammonemia	5
Author Index 2024	5
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder	5
Hematological and Other Cancers in People Using Clozapine	5
A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)	5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?	5
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants	5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder	5
Subject Index 2022	5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD	5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders	5
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder	5
Clozapine Associated Periorbital Edema in First Episode Psychosis	5
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs	5
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	5
Neurotoxicity Related to Multidrug Association: A Case Report	4
Characterization of Extended-Release Lorazepam	4
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder	4
Esketamine for Unipolar Major Depression With Psychotic Features	4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation	4
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	4
Methylphenidate-Associated Syncope	4
The Need for Non-profit Psychiatric Drug Discovery and Development	4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report	4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination	4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder	4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	4
Exploring the Addictive Potential of Tranylcypromine	4
Response to Letter to the Editors From Prof D. Taylor	4
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly	4
You Shall Not Turn a Blind Eye to Intraocular Pressure	4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users	4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty	4
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients	4
Detecting Anxious Distress, an Important Mood Specifier	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma	4
Article Selected to Receive the Mitchell B. Balter Award for 2022	4
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms	4
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients	4
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	4
Evaluating the Quality of Randomized Controlled Trials	3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit	3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion	3
Journal of Clinical Psychopharmacology Updates	3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient	3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia	3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth	3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse	3
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome	3
Risk of Neutropenia Associated With Duloxetine	3
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression	3
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders	3
α-PVP Associated Psychosis	3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease	3
A First Trimester Exposure to Ketamine and Esketamine for Depression	3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism	3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine	3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine	3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings	3
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	3
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”	3

Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”	3
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data	3
Tardive Dyskinesia Suppressed With Ginkgo Biloba	3
Global Insights Into Antipsychotic Research	3
Ketamine and Esketamine for Depression in Daily Practice	3
Assessing Adherence to Clozapine	3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium	3
Journal of Clinical Psychopharmacology Updates	3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder	3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination	3
Panic Disorder Seeks More Specific Drugs for Treatment	3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine	3
Toxidrome of an Easily Obtainable Nootropic	3
How Does Drug Company Marketing Affect Physician Prescribing?	3
Severe Alprazolam Withdrawal With Delirium and Psychosis	3
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States	3
Sertraline-Associated Burning Mouth Syndrome	3
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications	3
Venlafaxine-Associated Rhabdomyolysis	3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia	3
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period	3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms	3
Prebiotic Treatment in People With Schizophrenia	2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I	2
Question	2
Ketamine's Altered States Meta-Analysis	2
Late-Onset Neutropenia With Clozapine Associated With Lithium Carbonate–Related Hyperthyroidism	2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia	2
Endoxifen Approval for Bipolar Disorder in India	2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder	2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic	2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine	2
Modafinil Use in an Adolescent With Major Depressive Disorder	2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	2
Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy	2
Semaglutide-Mediated Lithium Toxicity	2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia	2
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors	2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	2
Pleural Effusion Associated With Divalproex Sodium	2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia	2
The Synergistic Effect of Bupropion-Dextromethorphan With Thyroid Supplementation in Treatment-Resistant Depression	2
Statistical Versus Clinical Significance	2
Blepharospasm Arising From Escitalopram Use	2
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics	2
Painful Ejaculation Associated With Atomoxetine and Bupropion	2
Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression	2
Further Studies of Effects of Finasteride on Mood and Suicidal Risk	2
Direct-to-Consumer Advertising Survey of Psychiatrists in Massachusetts and Michigan	2
Catatonia Associated With Valbenazine Treatment	2
Question	2
Fact Versus Fear	2
Treatment History Characteristics Associated With Use of Isocarboxazid	2
Question	2
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use	2
Gastrointestinal Hemorrhage After Antidepressant Drug Use	2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals	2
Sleep-wake Disorders	2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	2
Hypotension and Peripheral Edema With Moclobemide	2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	2
Citalopram-Associated Hyponatremia Presenting as Distal Extremity Numbness	2
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes	2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania	2
Question	2
Question	2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	2
Citalopram Associated with the Development of Tinnitus in an Adolescent Girl	2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics	2
Hypertensive Emergency and Stroke With Medication Interaction	2
A Systematic Review to Determine if Family History of Response to Medication Predicts Outcome in Mood Disorders	2
Variability in Response to Antidepressants	2
Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association	2
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital	2
Existing and Emerging Technologies for Therapeutic Monitoring of Lithium	2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression	2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder	2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine	2
The Rise and Fall of the Age of Psychopharmacology	2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia	2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder	2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder	2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders	2
Advancing the Development of New Medications to Treat Psychiatric Illness	2
Antidepressant Poisoning Trends in Pediatric Intensive Care	2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	2